| Bioactivity | Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer[1]. |
| Name | Serplulimab |
| CAS | 2231029-82-4 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141. |